Novo Nordisk A/S
-
Business
Zepbound could propel Eli Lilly to become the first $1 trillion pharma stock
Eli Lilly is creating a fortress with its diabetes and anti-obesity medications that could position it to become the first…
Read More » -
Business
Ozempic effect has hurt a weight loss stock that’s still a top pick
Game-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived…
Read More » -
Business
Obesity medicine euphoria warning: Experts tackle ‘miracle drugs’
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News…
Read More » -
Business
Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
Shares of kidney dialysis providers fell sharply Wednesday after Novo Nordisk said a study showed its Ozempic drug could delay…
Read More » -
Business
Morgan Stanley sees tough times ahead for snack stocks like Hostess
J.M. Smucker ‘s plan to buy Twinkies -maker Hostess Brands is a risky move, if Morgan Stanley’s latest research is…
Read More » -
Business
How much is a good night’s sleep worth? A lot to these stocks
If you’re like many Americans, you probably don’t feel like you are getting enough sleep every night. In fact, some…
Read More » -
Business
Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois,…
Read More »